Effect of ZEB1 Associated with microRNAs on Tumor Stem Cells in Head and Neck Cancer

Author(s)

Ferreira, Leticia Antunes Muniz ; Bezerra, Maria Antonia dos Santos ; Kawasaki-Oyama, Rosa Sayoko ; Fernandes, Glaucia Maria de Mendonca ; Castanhole-Nunes, Marcia Maria Urbanin ; Serafim Junior, Vilson ; Castilho, Rogerio Moraes ; Pavarino, Erika Cristina ; Maniglia, Jose Victor ; Goloni-Bertollo, Eny Maria

• Document type: Journal article
• Source: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; v. 24, n. 6, p. 15-pg., 2023-03-01.

Abstract

Cancer biologists have focused on studying cancer stem cells (CSCs) because of their ability to self-renew and recapitulate tumor heterogeneity, which increases their resistance to chemotherapy and is associated with cancer relapse. Here, we used two approaches to isolate CSCs: the first involved the metabolic enzyme aldehyde dehydrogenase ALDH, and the second involved the three cell surface markers CD44, CD117, and CD133. ALDH cells showed a higher zinc finger E-box binding homeobox 1 (ZEB1) microRNA (miRNA) expression than CD44/CD117/133 triple-positive cells, which overexpressed miRNA 200c-3p: a well-known microRNA ZEB1 inhibitor. We found that ZEB1 inhibition was driven by miR-101-3p, miR-139-5p, miR-144-3p, miR-199b-5p, and miR-200c-3p and that the FaDu Cell Line inhibition occurred at the mRNA level, whereas HN13 did not affect mRNA expression but decreased protein levels. Furthermore, we demonstrated the ability of the ZEB1 inhibitor miRNAs to modulate CSC-related genes, such as TrkB, ALDH, NANOG, and HIF1A, using transfection technology. We showed that ALDH was upregulated upon ZEB1-suppressed miRNA transfection (Mann-Whitney ** p(101) = 0.009, t-test ** p(139) = 0.009, t-test ** p(144) = 0.002, and t-test *** p(199) = 0.0006). Overall, our study enabled an improved understanding of the role of ZEB1-suppressed miRNAs in CSC biology. (AU)

• FAPESP's process: 16/20087-1 - Evaluation of miRNAs expression that regulates the ZEB1, involved in epithelial-mesenchymal transition in head and neck cancer stem cells
• Grantee: José Victor Maniglia
• Support Opportunities: Regular Research Grants